A new treatment product showed promising results in clinical trials when it comes to preventing hair loss during chemotherapy sessions among female breast cancer patients.
Researchers have identified a key protein release by primary tumor cells which causes holes in the bone. Blocking the protein could prevent secondary spread of the cancer.
While Rosehip extract was found to reduce cell proliferation in triple-negative breast cancers, estrogen therapy for postmenopausal women was found to lower risk of cancer.
According to a new study, minority women were less likely than white women to factor reputation while selecting healthcare providers.
Tamoxifen is a primary breast cancer prevention treatment that is known for a long time to be effective. A new study suggests that the drug appears to be more effective with more applications and dosages over the long term.
